Activated ERK1/2 and phosphorylated oestrogen receptor α are associated with improved breast cancer survival in women treated with tamoxifen-Reference-Cited by-同舟云学术

Activated ERK1/2 and phosphorylated oestrogen receptor α are associated with improved breast cancer survival in women treated with tamoxifen

Published:2006-05 Issue:8 Volume:42 Page:1104-1112
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Bergqvist Jenny,Elmberger Goran,Ohd John,Linderholm Barbro,Bjohle Judith,Hellborg Henrik,Nordgren Hans,Borg Anna-Lena,Skoog Lambert,Bergh Jonas

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference30 articles.

1. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005;365:1687–717.

2. The impact of hormone receptor status on the clinical efficacy of the new-generation aromatase inhibitors: a review of data from first-line metastatic disease trials in postmenopausal women;Buzdar;Breast J,2004

3. Breast cancer endocrine resistance: how growth factor signaling and estrogen receptor coregulators modulate response;Schiff;Clin Cancer Res,2003

4. ERBB2 amplification is associated with tamoxifen resistance in steroid-receptor positive breast cancer;Borg;Cancer Lett,1994

5. Twenty-year results of the Naples GUN randomized trial: predictive factors of adjuvant tamoxifen efficacy in early breast cancer;De Placido;Clin Cancer Res,2003

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tanshinone IIA potentiates the chemotherapeutic effect of doxorubicin against breast cancer cells and attenuates the cardiotoxicity of doxorubicin by regulating ERK1/2 pathway;Journal of Biochemical and Molecular Toxicology;2024-09-12

2. Tamoxifen Response at Single-Cell Resolution in Estrogen Receptor–Positive Primary Human Breast Tumors;Clinical Cancer Research;2023-09-25

3. An Overview of CDK Enzyme Inhibitors in Cancer Therapy;Current Cancer Drug Targets;2023-09

4. Phosphorylation of nuclear receptors: Novelty and therapeutic implications;Pharmacology & Therapeutics;2023-08

5. Tamoxifen Response at Single Cell Resolution in Estrogen Receptor-Positive Primary Human Breast Tumors;2023-04-03